Highlights Advicenne

Equities

ALDVI

FR0013296746

Market Closed - Euronext Paris Other stock markets 16:29:34 09/05/2024 BST			5-day change	1st Jan Change
1.8 ^EUR	+5.76%		+11.80%	-32.33%

04-08	Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-25	Advicenne: ODD designation in cystinuria	CF

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	04-07	CI
Advicenne: share price hit after 2023 sales figures	01-24	CF
Advicenne: launch of a capital increase	11/09/23	CF
Advicenne S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	10/09/23	CI
Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
Advicenne Announces the Launch of Sibnayal in Denmark	06/03/23	CI
Advicenne Completes European Commercial Coverage of Sibnayal(R) Through Its Agreement with Avanzanite Bioscience	28/02/23	CI
Advicenne and SPA Società Prodotti Antibiotici Announce an Exclusive Distribution Agreement for the Marketing of Sibnayal® in Italy, Spain and Portugal	14/02/23	CI
Advicenne Provides an Update on Its Commercial Partnerships in Europe and the Middle East	01/02/23	CI
Advicenne S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	20/09/22	CI
Advicenne Updates on Availability of Sibnayal to Patients and Caregivers in Great Britain	14/09/22	CI
Advicenne Announces Commercial Launch of Sibnayal in Great Britain	30/06/22	CI
France's Advicenne Taps Oman-based Distributor for Kidney Disease Drug	28/06/22	MT
Advicenne S.A. Signs an Exclusive Distribution Agreement with Taïba Healthcare	28/06/22	CI
Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
Advicenne Announces the Release of Results of a Study Showing Improved Quality of Life in Patients Living With DRTa and Treated by ADV7103	30/03/22	CI
Advicenne Moves Listing To Euronext Growth Paris	28/03/22	MT
Advicenne Wins Shareholder Nod to Move Listing to Euronext Growth Paris	24/01/22	MT
Advicenne Signs Nordic Distribution Deal For Renal Disease Drug	04/01/22	MT
Advicenne Announces Commercialization Agreement with FrostPharma AB for Sibnayal™ in the Nordic Region	04/01/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Advicenne

Equities

ALDVI

FR0013296746

Highlights

Filters